As the BIOME 2017 Annual Conference approaches, we invite you to get to know the professionals who will be delivering the event’s feature presentations. Our keynote presenter is Mike Bonney; the Maine Panel is moderated by Norman Moore, PhD of Alere; on the Panel we will have: Catherine Kaczorowski, PhD of Jackson Lab, Todd Keiller of MMCRI, Bryan Briggs of Idexx and Stephen Pelsue, PhD of BBI. Read bios
As the BIOME 2017 Annual Conference approaches, we invite you to get to know the professionals who will be delivering the event’s feature presentations.
Michael W. Bonney
Mike, former Partner at Third Rock Ventures, was the CEO and Director of Cubist Pharmaceuticals from 2003 until his retirement at year end 2014. Under Mike’s leadership Cubist grew from a struggling micro-cap to the world’s leading antibiotic company. Cubist was acquired by Merck early in 2015. Prior to Cubist, Mike was Chief Commercial Officer at Biogen, Inc. following a 12-year career at Zeneca Pharmaceuticals (and predecessor companies) in a range of commercial, operating and strategic roles, ending his career there as National Business Director. Mike currently chairs the boards of Alnylam Pharmaceuticals, Magenta Therapeutics, and Bates College. He is also a member of the boards of CELGENE Corporation, Revolution Medicine, Tekla Capital Management (closed end mutual fund complex), and the Whitehead Institute for Biomedical Research.
Norman Moore, PhD
Dr. Moore received his Bachelor’s Degree in biology and philosophy from Dartmouth College and his PhD in microbiology from the University of New Hampshire. Among other assays, he developed the first ever rapid tests for Legionella and S. pneumoniae, both of which are now recommended by the Infectious Disease Society of America. After being an R&D director at Alere for many years, he took the role of Director of Scientific Affairs where he works with the medical community. He has served on multiple NIAID grant committees, the CDC guideline group for rapid influenza testing, the College of American Pathology’s and Clinical Laboratory Standards point-of care committees, and CLSI’s infectious disease guideline writing committee. He currently has six patents and numerous publications and presentations.
Catherine Cook Kaczorowski, PhD
Dr Kaczorowski is an Assistant Professor of Neuroscience at Jackson Laboratory in Bar Harbor. She leads a collaborative and interinstitutional research program that uses a multidisciplinary approach to identify early causative events underlying ‘normal’ nonpathological age-related memory decline and Alzheimer’s dementia (AD). Using exemplary paradigms and strategies that she developed, Dr Kaczorowski sees immense potential to develop her future research program focused on elucidating the genetic, molecular, cellular and neuronal network mechanisms underlying ‘normal’ aging and AD memory failure. Her research program combines systems genetics with her expertise in electrophysiological recordings in freely behaving mice, whole-cell patch-clamp physiology in brain slices, proteomics, and viral-based gene transduction techniques. My lab uses a highly unique skill set and mentality to discover, validate, and determine mechanisms that underlie ‘normal’ aging and Alzheimer’s memory failure.
Stephen Pelsue, PhD
Stephen C. Pelsue, Ph.D. is the Scientific Director at BBI Solutions, Maine site (formerly Maine Biotechnology Services, Inc.). BBI solutions is a global leader in providing critical reagents and custom development for the In Vitro Diagnostic market. BBI Solutions (Maine) is focused on custom antibody development and production for the biotechnology and biopharma sector. Prior to joining BBI Solutions (Maine Biotechnology Services), he was a Faculty member at the University of Southern Maine, in the Applied Medical Sciences Department. During his tenure there he served as Department Graduate Coordinator, Department Chair, and Associate Dean of the College of Science, Technology, and Health. He received his B.S. in Chemistry from Northland College (Ashland, WI) and Ph.D. (Biochemistry) from North Carolina State University (Raleigh, NC), followed by a post-doctoral Fellowship at The Jackson Laboratory (Bar Harbor, ME).
Mr. Briggs joined IDEXX in May 2016 and oversees OPTI Medical’s worldwide commercial sales channels and global marketing initiatives. Prior to joining the company Mr. Briggs was Vice President Sales, Marketing and Innovation from 2013 to 2016 at FHC a Maine based human use medical device manufacturer providing surgical devices and surgical planning software for functional neurosurgeons globally. At FHC he focused on expanding the company’s global sales presence, implementing sales processes, optimizing global sales strategy, guiding product innovation and activating an enhanced customer contact system. Mr. Briggs also held senior sales leadership and marketing positions at The Coca Cola Company as Group Manager Operational Marketing and at Cox Enterprise as Northeast Region Manager for its web based and print automotive portals. Mr. Briggs has extensive experience in global sales, marketing and finance. Mr. Briggs holds a bachelor’s degree in Business Administration from the University of Maine at Orono and an MBA from the University of Rhode Island’s Graduate School of Business. He lives in Cumberland Maine with his wife Debbie and 15 year old daughter Catie.
Todd has been providing a “plug in” technology transfer office for a variety of institutions since 1995. He has been the Director of Technology Transfer for Maine Medical Center Research Institute since 2004. In addition,he is the Director Intellectual Property and Innovation at Worcester Polytechnic Institute and assists Baystate Medical, the University of New England, and Clark University with all aspects of their intellectual property. He provides the process to manage any new ideas generated from the faculty. He uses his experience and background to encourage new IP, but also gets commercial feedback in order to prudently manage the expense associated with filing patents. Previously, Todd started and grew the tech transfer program for the University of Vermont and was Vice President, Ventures at Brigham and Women’s Hospital. He came from industry where he served in marketing and business development roles in start-ups, early stage companies, and spent 10 years at Corning. He was hired by MTI in 2016 to review all non-profit intellectual activity in Maine, and currently serves on the Board of the Maine Center for Entrepreneurial Development.